Spravato®Registry-verifiedDesignated-centers model

Hôpitaux Universitaires de Genève (HUG)

Genève, Switzerland

Treatment & access

Treatments offeredEsketamine nasal spray (Spravato®)
Access routeCovered by a national programme
Cost & coverage (registry status)Reimbursed by mandatory health insurance (OKP/AOS) per SL Limitatio
ReimbursementBAG Spezialitätenliste Limitatio: cantonal psychiatric care mandate required; list valid 2025-10-01 to 2028-09-30 How reimbursement works in Europe →
Phone+41 22 305 45 11
Websitehttps://www.hug.ch/specialites-psychiatriques/unite-humeur-anxiete-uha

Related listings

These records belong to the same organisation. They are listed separately because each is a distinct programme or location.

Location in Collonge-BelleriveUniversity Hospital Geneva, Palliative medicine department : Clinical trials
Another programme at this clinicLouise Penzenstadler (Hôpitaux Universitaires de Genève (HUG), Dépt. Psychiatrie) : PAT
Another programme at this clinicMichel Sabé (Hôpitaux Universitaires de Genève (HUG)) : PAT
Another programme at this clinicGabriel Thorens (Hôpitaux Universitaires de Genève (HUG)) : PAT

About this provider

The Hôpitaux Universitaires de Genève (HUG) are Geneva's university hospitals and a national reference centre. Depression care is organised through the Mood & Anxiety Unit (Unité Humeur & Anxiété, UHA) of the psychiatric specialties service, which treats unipolar depression, bipolar and anxiety disorders with intensive multidisciplinary follow-up, pharmacological optimisation, individual psychotherapy, psychoeducation and adjuncts such as light therapy and mindfulness-based approaches. HUG's own magazine reports that esketamine nasal spray has been used in its mood disorders unit under close medical supervision for patients not helped by standard treatments.

Services & programs

Esketamine nasal spray used in the mood disorders unit under close medical supervision (reported by HUG's Pulsations magazine)
Specialised Mood & Anxiety Unit (UHA) with a unipolar depression program
Light therapy and mindfulness-based approaches as adjuncts to pharmacological treatment

Common questions

How do I access esketamine (Spravato) treatment here?

Access runs through a psychiatrist. Your treating psychiatrist assesses whether you meet the Swiss criteria for treatment-resistant depression and refers you to the specialised unit.

Is the treatment covered by health insurance?

Spravato is reimbursed by Swiss mandatory health insurance for treatment-resistant depression within the official criteria; the insurer must issue a cost approval (garantie de prise en charge) before the first dose.

Looking at alternatives? This is one of the BAG-designated Spravato centers in Switzerland; see the country guide for the full route and the limited-medical-use PAT program.

5 more verified providers within 50 km

Carouge · 2 kmLoraine Biéler : PAT
Lancy · 3 kmBraulio Mora : PAT
Collonge-Bellerive · 7 kmUniversity Hospital Geneva, Palliative medicine department : Clinical trials

See them on the provider map →

Verification

License / registryBAG SL Limitatio
Official registryhttps://www.bag.admin.ch/dam/de/sd-web/uo93E02fcJBh/Liste%20der%20Zentren%20gem%C3%A4ss%20der%20Limitierung%20von%20Spravato_20251001.pdf
Last verified2026-07-05

Re-checked every 90 days · how we verify and report corrections

Check your fit & enquire

Check my fit & enquire

Free 2-minute pre-screening in your browser · your summary goes only to Hôpitaux Universitaires de Genève (HUG), with your consent.

What to prepare before you enquire

A referral or the contact details of your treating clinician
A list of medications you have tried (names, doses, duration)
A short diagnosis summary or discharge letters

Esketamine programmes usually require a documented history of antidepressant treatment.

Send documents directly to the provider when they reply. We never ask you to upload medical records.

Check my fit & enquire